The complex association between the antioxidant defense system and clinical status in early psychosis
Year: 2018
Type: article
Study design: Observational Study
Abstract: Oxidative stress is a pathophysiological mechanism potentially involved in psychiatric disorders. The objective of this study was to assess the relationship between total antioxidant status (TAS) and the functional status of patients with a first episode of psychosis at the onset of the disease. For this purpose, a sample of 70 patients aged between 9 and 17 years with a first episode of psychosis were followed up for a period of two years. Blood samples were drawn to measure TAS levels at three time points: at baseline, at one year, and at two years. Clinical symptoms and functioning were also assessed at the same time points using various scales. Linear regression analysis was performed to investigate the relationship between TAS and clinical status at each assessment, adjusting for potential confounding factors. The distribution of clinical variables was grouped in different percentiles to assess the dose-response in the relation between clinical variables and TAS. At baseline, patient's score on Children's Global Assessment Scale (CGAS) was directly and significantly associated with TAS with a monotonic increase in percentiles, and surprising this association was reversed after one and two years of follow-up with a monotonic decrease. In summary at the onset of the illness, TAS is positively related to clinical status, whereas as the illness progresses this correlation is reversed and becomes negative. This may be the result of an adaptive response.
Source: PLoS ONE
Institutions: University of the Basque Country, Centro de Investigación Biomédica en Red de Salud Mental, Hospital Universitario Araba, Universidad Nacional de Educación a Distancia, Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Universidad de Cádiz, Biomedical Research and Innovation Institute of Cadiz, Hospital Infantil Universitario Niño Jesús, Universidad de Cantabria, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, Hospital Universitario Miguel Servet
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: Amgen, Pfizer, AstraZeneca, Fundación Alicia Koplowitz, Ministerio de Economía y Competitividad, Ministerio de Ciencia e Innovación, Centro de Investigación Biomédica en Red de Salud Mental, Servier, H. Lundbeck A/S, Instituto de Salud Carlos III, European Regional Development Fund, Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa, Cilag
OpenAlex ID: W2801229673
